3 completed, 1 active not recruiting, 1 not yet recruiting. 2 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Active not recruiting 1, Completed 1 |
| Phase 4 | 1 | Completed 1 |
Follow Erythrodermic Psoriasis: new trials by email Literature Review of Erythrodermic Psoriasis trials Research Report on Erythrodermic Psoriasis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of Injection Sekucinumab in Erythrodermic Psoriasis injection Sekucinumab - Erythrodermic Psoriasis | Not yet recruiting | Jinnah Postgraduate Medical Centre | 60 | 2025-01-20 | 2025-01-30 | |
| A Study of TAK-279 in Adult Participants With Generalized Pustular Psoriasis or Erythrodermic Psoriasis TAK-279 - Generalized Pustular Psoriasis, Erythrodermic Psoriasis | Phase 3 | Completed | Takeda | 18 | 2024-03-19 | 2026-11-04 |
| A Study of JNJ-77242113 for the Treatment of Participants With Generalized Pustular Psoriasis or Erythrodermic Psoriasis JNJ-77242113 - Generalized Pustular Psoriasis, Erythrodermic Psoriasis | Phase 3 | Active not recruiting | Janssen Pharmaceutical K.K. | 19 | 2024-02-09 | 2026-09-28 |
| Infliximab Biosimilar for Intravenous Drip Infusion 100 mg "Pfizer" Drug Use Investigation (Psoriasis) Infliximab [infliximab biosimilar 3] - Psoriasis Vulgaris, Psoriasis Arthropathica | Completed | Pfizer | 10 | 2019-10-21 | 2025-06-19 | |
| A Study of Ixekizumab (LY2439821) in Participants in Japan With Generalized Pustular Psoriasis and Erythrodermic Psoriasis Ixekizumab - Generalized Pustular Psoriasis, Erythrodermic Psoriasis | Phase 4 | Completed | Eli Lilly and Company | 12 | 2019-07-05 | 2021-08-13 |
Psoriasis (3) · Arthritis, Psoriatic (1)
Skin Diseases (4) · Skin Diseases, Papulosquamous (4) · Skin and Connective Tissue Diseases (4) · Arthritis (1) · Bone Diseases (1) · Joint Diseases (1) · Musculoskeletal Diseases (1) · Psoriasis (1) · Spinal Diseases (1) · Spondylarthritis (1) · Spondylarthropathies (1) · Spondylitis (1)
Infliximab (1) · ixekizumab (1)
Eli Lilly and Company (1) · Janssen Pharmaceutical K.K. (1) · Jinnah Postgraduate Medical Centre (1) · Pfizer (1) · Takeda (1)
Japan (4) · Pakistan (1)
Maria Iqbal, MBBS, FCPS Trainee (1)